Safety and Efficacy of LDL-C Reduction

New Oral Options for Diabetic Dyslipidemia Management

New Oral Options for Diabetic Dyslipidemia Management

Type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular …

Expiration Date: 6/29/2021

Max Credits: 0

View Activity

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

In the United States, cardiovascular disease (CVD) is the leading cause of…

Expiration Date: 1/20/2021

Max Credits: 0

View Activity

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have prov…

Expiration Date: 7/15/2020

Max Credits: 0

View Activity

Rapid-Fire Roundtable: Addressing Clinical Challenges Regarding the Use of PCSK9 Inhibitors

Rapid-Fire Roundtable: Addressing Clinical Challenges Regarding the Use of PCSK9 Inhibitors

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have prov…

Expiration Date: 1/13/2020

Max Credits: 0

View Activity

Test Your Knowledge in the Use of PCSK9 Inhibitors in the Reduction of CV Risk: A Wheel of Knowledge Challenge

Test Your Knowledge in the Use of PCSK9 Inhibitors in the Reduction of CV Risk: A Wheel of Knowledge Challenge

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 1/9/2020

Max Credits: 0

View Activity

PCSK9 Inhibitors in Prevention: How to Use Them Like the Experts

PCSK9 Inhibitors in Prevention: How to Use Them Like the Experts

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 8/30/2019

Max Credits: 0

View Activity

Treating Diabetic Dyslipidemia: A Deep Dive into PCSK9 Inhibitors

Treating Diabetic Dyslipidemia: A Deep Dive into PCSK9 Inhibitors

Diabetes mellitus is associated with considerable increased risk of athero…

Expiration Date: 8/16/2019

Max Credits: 0

View Activity

Optimizing the Use of PCSK9 Inhibitors for Your Patients

Optimizing the Use of PCSK9 Inhibitors for Your Patients

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 5/28/2020

Max Credits: 0

View Activity

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Nearly one-third of adults in the United States have an elevated low-densi…

Expiration Date: 3/8/2019

Max Credits: 0

View Activity

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the cl…

Expiration Date: 8/11/2018

Max Credits: 0

View Activity